Is 18F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?

Minoru Shigekawa, Kenji Yamao, Akira Sawaki, Kazuo Hara, Tadayuki Takagi, Vikram Bhatia, Masami Nishio, Tsuneo Tamaki, Hussein El-Amin, Zain El-Abdeen, Ahmed Sayed, Nobumasa Mizuno

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Autoimmune pancreatitis (AIP) is often misdiagnosed as pancreatic cancer (PC). Both conditions accumulate 18F- fluorodeoxyglucose (FDG), so FDG positron emission tomography (FDG-PET) is not discriminatory. This study aimed to evaluate the pattern of FDG accumulation, and the change in FDG uptake after steroid treatment in AIP and PC. Methods: We compared FDG-PET patterns between 18 patients with AIP and 20 patients with PC, and also evaluated the short-term changes in FDG uptake after steroid therapy. Results: FDG uptake was observed in 88.9% in AIP and 90.0% in PC. FDG uptake in extra-abdominal lymph nodes was seen more frequently in AIP, and uptake in salivary glands, eyes and biliary ducts was seen only in AIP. Follow-up PET was performed in 6 AIP patients and in 3 PC patients. Changes in SUVmax after steroid therapy were estimated within 1 week in 5 AIP patients and in all 3 PC patients, retrospectively. In 4 AIP patients, the change in SUV max was more than 10%. On the other hand, in PC, SUVmax increased or remained almost unchanged (within 10%). Conclusions: FDG-PET pattern at baseline, and a decrease in FDG uptake after a short steroid trial can be useful for discriminating AIP from PC.

Original languageEnglish
Pages (from-to)269-274
Number of pages6
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume17
Issue number3
DOIs
Publication statusPublished - 01-05-2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Is <sup>18</sup>F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?'. Together they form a unique fingerprint.

  • Cite this

    Shigekawa, M., Yamao, K., Sawaki, A., Hara, K., Takagi, T., Bhatia, V., Nishio, M., Tamaki, T., El-Amin, H., El-Abdeen, Z., Sayed, A., & Mizuno, N. (2010). Is 18F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? Journal of Hepato-Biliary-Pancreatic Sciences, 17(3), 269-274. https://doi.org/10.1007/s00534-009-0172-9